A carregar...

Advertisement

Alpine Immune Sciences Appoints Wolfgang Dummer To Succeed Andrew Sandler As Chief Medical Officer

RTTNews | 692 dias atrás

Alpine Immune Sciences Appoints Wolfgang Dummer To Succeed Andrew Sandler As Chief Medical Officer

(RTTNews) - Alpine Immune Sciences, Inc. (ALPN), a clinical-stage immunotherapy company, announced Wednesday the appointment of Wolfgang Dummer, M.D., Ph.D., to Chief Medical Officer effective October 2, 2023.

Dummer succeeds Andrew Sandler, M.D., who will transition responsibilities to Dummer through the remainder of the year.

Dummer brings over 20 years of global drug development leadership experience and has led the development of multiple drug approvals in immunology and rare diseases. He joins Alpine from Rigel Pharmaceuticals, where he served as Chief Medical Officer.

Prior to his time at Rigel, Dummer served as Vice President of Clinical Development at BioMarin, and previously held various roles of increasing responsibility at Genentech where he was Global Development Leader for ocrelizumab and rituximab.

In conjunction with his employment, effective October 2, 2023, Dummer has been granted an option to purchase 200,000 shares of common stock.

Etiquetas: ALPN

read more

U.S. Consumer Confidence Index Edges Lower In August

U.S. Consumer Confidence Index Edges Lower In August

A report released by the Conference Board on Tuesday showing a modest deterioration by consumer confidence in the U.S. in the month of August. The Conference Board said its consumer confidence index dipped to 97.4 in August from an upwardly revised 98.7 in July.

RTTNews | 1 h 23 min atrás

U.S. Durable Goods Orders Slump 2.8% In July, Much Less Than Expected

U.S. Durable Goods Orders Slump 2.8% In July, Much Less Than Expected

Reflecting a continued plunge by orders for transportation equipment, the Commerce Department released a report on Tuesday showing a steep drop by new orders for U.S. manufactured durable goods in the month of July. The Commerce Department said durable goods orders slumped by 2.8 percent in July after plummeting by a revised 9.4 percent in June.

RTTNews | 1 h 34 min atrás

Bay Street May Open On Weak Note

Bay Street May Open On Weak Note

Canadian shares look headed for negative start on Tuesday, weighed down by weak oil prices, and concerns about global trade after U.S. President Donald Trump threatened 200% tariffs on China if Beijing does not export rare-earth magnets to the U.S.

RTTNews | 2 h 53 min atrás

U.S. Durable Goods Orders Tumble Less Than Expected In July

U.S. Durable Goods Orders Tumble Less Than Expected In July

Reflecting a continued plunge by orders for transportation equipment, the Commerce Department released a report on Tuesday showing a steep drop by new orders for U.S. manufactured durable goods in the month of July.

RTTNews | 2 h 59 min atrás

FTSE 100 Modestly Lower

FTSE 100 Modestly Lower

After posting gains in the previous five sessions, the U.K. market is exhibiting weakness on Tuesday, weighed down by losses in financials and retail sectors.

RTTNews | 3 h 21 min atrás

CAC Down Sharply On Widespread Selling

CAC Down Sharply On Widespread Selling

French stocks are down sharply on Tuesday, extending previous session's steep drop, amid ongoing political uncertainty in the country.

RTTNews | 3 h 46 min atrás

DAX Extending Recent Weakness

DAX Extending Recent Weakness

German stocks are down in negative territory on Tuesday, extending losses from the previous session, due to geopolitical concerns and uncertainty about tariffs.

RTTNews | 5 h 9 min atrás

Sensex, Nifty Tumble On Tariff Worries

Sensex, Nifty Tumble On Tariff Worries

Indian shares tumbled on Tuesday after the Trump administration officially issued a notice regarding the imposition of an additional 25 percent tariffs on Indian imports, with the punitive duties set to kick in at 12:01 am (EST) on August 27.

RTTNews | 5 h 13 min atrás

Termos | Privacidade | Mapa do SIte | Site Map Calendar

© 2025 Myfxbook Ltd Todos os Direitos Reservados.

AVISO DE ALTO RISCO: A negociação em moeda estrangeira comporta um alto nível de risco que pode não ser adequado para todos os investidores. A vantagem cria risco adicional e exposição a perdas. Antes de decidir negociar em moeda estrangeira, considere cuidadosamente os seus objetivos de investimento, nível de experiência e tolerância ao risco. Pode perder parte ou todo o seu investimento inicial. Não invista dinheiro que não possa perder. Eduque-se sobre os riscos associados à negociação em moeda estrangeira e procure aconselhamento de um consultor financeiro ou fiscal independente se tiver alguma dúvida. Quaisquer dados e informações são fornecidos apenas para fins informativos e não se destinam a fins comerciais ou de consultoria. O desempenho anterior não é indicativo de resultados futuros.